AGXT2 and tuberous sclerosis: Some enzymes (alanine-glyoxylate aminotransferase-2, tyrosine hydroxylase, dopa decarboxylase, etc.)related to metabolic biomarkers were predicted as the potential targets of TSC treatment on SHRs.